AVBP Operating Cash Flow (Statement)
Arrivent Biopharma Inc · Operating Cash Flow (Statement)
AVBP Operating Cash Flow (Statement)
Latest reported-$39.58Mperiod ending
AVBP Quarterly Cash from Operations (-$9.93M → -$39.58M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AVBP operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -39,581,000 | |
| -41,892,000 | |
| -30,658,000 | |
| -35,798,000 | |
| -26,124,000 | |
| -68,008,000 | |
| -16,152,000 | |
| -16,345,000 | |
| -19,087,000 | |
| -18,628,000 | |
| -14,913,000 | |
| -15,442,000 | |
| -8,606,000 | |
| -16,881,000 | |
| -15,887,000 | |
| -9,926,000 |